Harrison Iris, Forouzandeh Mahtab, Motaparthi Kiran
Department of Dermatology, University of Florida College of Medicine, Gainesville, USA.
Cureus. 2023 Sep 14;15(9):e45217. doi: 10.7759/cureus.45217. eCollection 2023 Sep.
Anti-tumor necrosis factor-alpha (TNF-⍺) inhibitors are commonly used in the treatment of inflammatory conditions such as psoriasis. However, these agents lead to increased susceptibility to infections. We report a patient with reactivation of latent histoplasmosis six months after starting an anti-TNF-⍺ inhibitor for the treatment of psoriasis. Dermatologists should be aware of the risks associated with initiating therapy and maintain a low threshold of suspicion for this infection in patients on anti-TNF-⍺ inhibitors presenting with oral ulcers.
抗肿瘤坏死因子-α(TNF-α)抑制剂常用于治疗银屑病等炎症性疾病。然而,这些药物会导致感染易感性增加。我们报告了一名患者,在开始使用抗TNF-α抑制剂治疗银屑病六个月后,潜伏性组织胞浆菌病复发。皮肤科医生应意识到开始治疗相关的风险,并对出现口腔溃疡的抗TNF-α抑制剂治疗患者保持对这种感染的低怀疑阈值。